Robert Stratta to Tacrolimus
This is a "connection" page, showing publications Robert Stratta has written about Tacrolimus.
Connection Strength
1.797
-
Stratta RJ, Shokouh-Amiri MH, Egidi MF, Grewal HP, Lo A, Kizilisik AT, Nezakatgoo N, Gaber LW, Gaber AO. Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression. Clin Transplant. 2003; 17 Suppl 9:69-77.
Score: 0.210
-
Stratta RJ, Alloway RR, Hodge E, Lo A. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis. Clin Transplant. 2002 Feb; 16(1):60-8.
Score: 0.197
-
Stratta RJ, Gaber AO, Shokouh-Amiri MH, Reddy KS, Alloway RR, Egidi MF, Grewal HP, Gaber LW, Hathaway D. Evolution in pancreas transplantation techniques: simultaneous kidney-pancreas transplantation using portal-enteric drainage without antilymphocyte induction. Ann Surg. 1999 May; 229(5):701-8; discussion 709-12.
Score: 0.163
-
Stratta RJ. Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: a multi-center report. The FK/MMF Multi-Center Study Group. Transplant Proc. 1997 Feb-Mar; 29(1-2):654-5.
Score: 0.139
-
Stratta RJ, Taylor RJ, Castaldo P, Sindhi R, Sudan D, Weide LG, Frisbie K, Cushing KA, Jerius J, Radio SJ. FK 506 induction and rescue therapy in pancreas transplant recipients. Transplant Proc. 1996 Apr; 28(2):991-2.
Score: 0.132
-
Henley SE, Larsen JL, Mack-Shipman L, Miller SA, Cushing KA, Stratta RJ. Lipids following pancreas transplantation in recipients receiving FK 506. Transplant Proc. 1995 Dec; 27(6):2997.
Score: 0.129
-
Stratta RJ, Taylor RJ, Castaldo P, Sindhi R, Sudan D, Frisbie K, Cushing K. Preliminary experience with FK 506 in pancreas transplant recipients. Transplant Proc. 1995 Dec; 27(6):3024.
Score: 0.129
-
Farney A, Sundberg A, Moore P, Hartmann E, Rogers J, Doares W, Jarrett A, Adams P, Stratta R. A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation. Clin Transplant. 2008 Jan-Feb; 22(1):41-9.
Score: 0.074
-
Stratta RJ, Alloway RR, Lo A, Hodge EE. Does surgical technique influence outcomes after simultaneous kidney-pancreas transplantation? Transplant Proc. 2004 May; 36(4):1076-7.
Score: 0.058
-
Stratta RJ, Lo A, Shokouh-Amiri MH, Egidi MF, Gaber LW, Gaber AO. Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression. Transpl Int. 2003 Mar; 16(3):154-60.
Score: 0.053
-
Bruce DS, Sollinger HW, Humar A, Sutherland DE, Light JA, Kaufman DB, Alloway RR, Lo A, Stratta RJ. Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients. Transplantation. 2001 Nov 27; 72(10):1637-43.
Score: 0.049
-
Hardinger KL, Stratta RJ, Egidi MF, Alloway RR, Shokouh-Amiri MH, Gaber LW, Grewal HP, Honaker MR, Vera S, Gaber AO. Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era. Surgery. 2001 Oct; 130(4):738-45; discussion 745-7.
Score: 0.048
-
Lo A, Stratta RJ, Egidi MF, Shokouh-Amiri MH, Grewal HP, Kisilisik AT, Trofe J, Alloway RR, Gaber LW, Gaber AO. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis. Transpl Infect Dis. 2001 Mar; 3(1):8-15.
Score: 0.046
-
Stratta RJ. Optimal immunosuppression in pancreas transplantation. Transplant Proc. 1999 Feb-Mar; 31(1-2):619-21.
Score: 0.040
-
Stratta RJ. Late acute rejection episodes after vascularized pancreas transplantation. Transplant Proc. 1998 Jun; 30(4):1560-1.
Score: 0.038
-
Elmer DS, Abdulkarim AB, Fraga D, Shokouh-Amiri H, Stratta RJ, Hathaway DK, Reddy K, Gaber AO. Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts. Transplant Proc. 1998 Mar; 30(2):523-4.
Score: 0.038
-
Gruessner RW, Burke GW, Stratta R, Sollinger H, Benedetti E, Marsh C, Stock P, Boudreaux JP, Martin M, Drangstveit MB, Sutherland DE, Gruessner A. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Transplantation. 1996 Jan 27; 61(2):261-73.
Score: 0.033
-
Shaefer MS, Collier DS, Haven MC, Langnas AN, Stratta RJ, Donovan JP, Sorrell MF, Shaw BW. Falsely elevated FK-506 levels caused by sampling through central venous catheters. Transplantation. 1993 Aug; 56(2):475-6.
Score: 0.027
-
Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, et al. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):635-7.
Score: 0.026
-
Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, et al. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):641-3.
Score: 0.026
-
Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, et al. Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):679-88.
Score: 0.026
-
Shaw BW, Markin R, Stratta R, Langnas A, Donovan J, Sorrell M. FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients. Transplant Proc. 1991 Dec; 23(6):2994-5.
Score: 0.024
-
Trofe J, Stratta RJ, Egidi MF, Lo A, Gaber LW, Shokouh-Amiri MH, Grewal HP, Honaker M, Hardinger K, Alloway RR, Gaber AO. Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience. Clin Transplant. 2002; 16 Suppl 7:34-44.
Score: 0.012
-
Lo A, Stratta RJ, Alloway RR, Egidi MF, Shokouh-Amiri MH, Grewal HP, Gaber LW, Gaber AO. Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation. Transpl Int. 2001 Dec; 14(6):396-404.
Score: 0.012
-
Shokouh-Amiri MH, Egidi MF, Lo A, Grewal HP, Vera SR, Stratta RJ, Kizilisik T, Nezakatgoo N, Trofe J, Alloway RR, Cowan PA, Gaber AO. The importance of early prevention of renal dysfunction in liver transplant recipients. Transplant Proc. 2001 Feb-Mar; 33(1-2):1399-400.
Score: 0.012
-
Lo A, Stratta RJ, Egidi MF, Shokouh-Amiri MH, Grewal HP, Kizilisik AT, Alloway RR, Gaber AO. Outcome of simultaneous kidney-pancreas transplantation in African-American recipients: a case control study. Transplant Proc. 2001 Feb-Mar; 33(1-2):1675-7.
Score: 0.012
-
Lo A, Stratta RJ, Alloway RR, Egidi MF, Shokouh-Amiri MH, Grewal HP, Gaber AO. Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation. Transplant Proc. 2001 Feb-Mar; 33(1-2):1701-3.
Score: 0.012
-
Lo A, Stratta RJ, Egidi MF, Kizilisik AT, Shokouh-Amiri MH, Grewal HP, Trofe J, Alloway RR, Gaber AO. Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone. Transplant Proc. 2001 Feb-Mar; 33(1-2):1796-8.
Score: 0.012
-
Reddy KS, Stratta RJ, Shokouh-Amiri H, Alloway R, Somerville T, Egidi MF, Gaber LW, Gaber AO. Simultaneous kidney-pancreas transplantation without antilymphocyte induction. Transplantation. 2000 Jan 15; 69(1):49-54.
Score: 0.011
-
Henley SA, Akhter J, Stratta RJ, Mack-Shipman LR, Miller SJ, Frisbie K, Taylor R, Erickson JM, Leone JP, Lyden E, Ratanasuwan T, Larsen JL. Lipids increase after solitary pancreas transplantation. Diabetes Care. 1999 Feb; 22(2):320-7.
Score: 0.010